Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow
Gorzów Wielkopolski, Lubusz Voivodeship, 66-400, Poland
NCT Number: NCT06403241
The study aimed to check the influence of timing and composition of diet on markers of gut injury, endotoxemia and stress.
Looking for future studies?
Notify Me18 year–23 year
Male
Observational
Gorzów Wielkopolski, Lubusz Voivodeship, 66-400, Poland
The research protocol includes detailed food intake analysis, including timing and composition, markers related to the neuroendocrine pathway cortisol, and observations of individually experienced symptoms. Moreover, the study also explores intestinal injury and endotoxemia parameters, such as I-FABP, CLDN-3, and LBP. As a first goal, this study investigates the timing and composition of food intake concerning changes in gut integrity, cortisol levels, and gastrointestinal symptoms. Investigators explored whether an athlete's nutritional intake influences any GI disturbance induced by high-intensity exercise. As a second goal, Investigators tried to connect symptoms and markers from both pathways with gastrointestinal complaints. Investigators hypothesised that cortisol levels would be more profound than other studied parameters in gastrointestinal symptoms.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Rowers performed 2000m ergometer test.A 2,000-m time trial is a standard test used to assess performance in rowers.
Time frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 1-hour recovery period
I-FABP concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays
Time frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 1-hour recovery period
Zonulin concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays
Time frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 1-hour recovery period
LBP concentration measured in blood [ug/ml] using commercially available enzyme-linked immunosorbent assays
Time frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test
Lactate concentration measured in capillary blood from earlobe [mmol/L] using a commercially available kit (Diaglobal, Berlin, Germany)
Time frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 1-hour recovery period
Stress hormoneconcentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays
Time frame: whole day (24hours) before test, in the morning before the test
energy [kcal ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
protein [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
fat [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
carbohydrate [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
glucose [g ]of food intake measured by food diary
Time frame: whole day(24hours) before test, in the morning before the test
lactose [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
saccharose [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
fructose [g ]of food intake measured by food diary
Time frame: whole day (24hours) before test, in the morning before the test
fiber [g ]of food intake measured by food diary
Time frame: in the morning before the test up to 1 hour after getting up
Body mass [kg] measured by electronic scale to the nearest 0,05 kg (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan).
Time frame: in the morning before the test up to 1 hour after getting up
Body fat [%] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan).
Time frame: in the morning before the test up to 1 hour after getting up
Body fat [%] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan).
Time frame: in the morning before the test up to 1 hour after getting up
Lean body mass [kg] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan).
Time frame: in the morning before the test up to 1 hour after getting up
[cm] measured by high meter
Time frame: up to 1 hours after the test
10 point scale
Poznan University of Physical Education
Other
The Association Between Food Timing and Composition on Gastrointestinal Injury, Stress Hormone and Gastrointestinal Complains in Elite Rowers After 2000m Ergometer Test - an Observational Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03624569
Bacteremia, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial DetailsNCT05001126
Atherogenic Dyslipidemia, Behavior
Gunnison, Colorado, United States
View Trial DetailsNCT02853747
Behavior, Body Weight
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT03451201
Autoimmune Diseases, Behavior
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details